Vanguard Group Inc Nexgel, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Nexgel, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 25,526 shares of NXGL stock, worth $53,349. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,526
Previous 25,526
-0.0%
Holding current value
$53,349
Previous $54,000
27.78%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NXGL
# of Institutions
14Shares Held
155KCall Options Held
0Put Options Held
0-
Simon Quick Advisors, LLC35.7KShares$74,6440.01% of portfolio
-
Geode Capital Management, LLC Boston, MA30.3KShares$63,2720.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny25.6KShares$53,5680.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il15.4KShares$32,1460.0% of portfolio
-
Northeast Financial Group, Inc. Tannersville, PA11.8KShares$24,7620.01% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $11.6M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...